These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19645063)

  • 1. Polyglandular autoimmune syndrome type 3 in a patient with ocular myasthenia gravis.
    Briscoe NK; Mezei MM
    Muscle Nerve; 2009 Dec; 40(6):1064-5. PubMed ID: 19645063
    [No Abstract]   [Full Text] [Related]  

  • 2. Infantile anti-MuSK positive myasthenia gravis in a patient with autoimmune polyendocrinopathy type 3.
    Duman O; Koken R; Baran RT; Haspolat S; Topaloglu H
    Eur J Paediatr Neurol; 2014 Jul; 18(4):526-8. PubMed ID: 24685514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune polyglandular syndrome type 2 with myasthenia gravis crisis.
    Konno S; Ichijo T; Murata M; Toda T; Nakazora H; Nomoto N; Sugimoto H; Nemoto H; Kurihara T; Wakata N; Fujioka T
    Neurologist; 2009 Nov; 15(6):361-3. PubMed ID: 19901721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune polyglandular syndrome, type 2 associated with myasthenia gravis].
    Pejin R; Stokić E; Novković M; Banić-Horvat S; Cvijanović M
    Vojnosanit Pregl; 2012 Apr; 69(4):358-62. PubMed ID: 22624429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune spontaneous chronic urticaria and generalized myasthenia gravis in a patient with polyglandular autoimmune syndrome type 3.
    De Marchi SU; Cecchin E; De Marchi S
    Muscle Nerve; 2015 Sep; 52(3):440-4. PubMed ID: 25808274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome and myasthenia gravis in the context of autoimmune polyendocrine syndrome type III.
    Rispoli MG; Ferri L; Ajdinaj P; Falzano V; Di Muzio A
    Neurol Sci; 2021 Nov; 42(11):4789-4792. PubMed ID: 34331156
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of autoimmune urticaria accompanying autoimmune polyglandular syndrome type III associated with Hashimoto's disease, type 1 diabetes mellitus, and vitiligo.
    Kasznicki J; Drzewoski J
    Endokrynol Pol; 2014; 65(4):320-3. PubMed ID: 25185856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From macrocytosis to incomplete autoimmune polyglandular syndrome type 2: a poorly known entity.
    Wehbe E; Peery WH
    J Intern Med; 2008 Mar; 263(3):333-4. PubMed ID: 18205764
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acquired von Willebrand's disease in the course of severe primary hypothyroidism in a patient with autoimmune polyglandular syndrome type 3].
    Lubińska M; Swiatkowska-Stodulska R; Kazimierska E; Sworczak K
    Endokrynol Pol; 2008; 59(1):34-7. PubMed ID: 18335399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucocutaneous candidiasis as first manifestation of autoimmune polyglandular syndrome type I.
    López-Jornet P; García-Ballesta C; Pérez-Lajarín L
    J Dent Child (Chic); 2005; 72(1):21-4. PubMed ID: 16119071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand's syndrome in a patient with severe primary hypothyroidism associated with myasthenia gravis in the course of autoimmune polyglandular syndrome type 3.
    Lubinska M; Swiatkowska-Stodulska R; Kazimierska E; Sworczak K
    Haemophilia; 2007 Sep; 13(5):675-6. PubMed ID: 17880463
    [No Abstract]   [Full Text] [Related]  

  • 12. Oculomotor signs in Lambert-Eaton myasthenic syndrome-coincidence with myasthenia gravis.
    Toyka KV; Schneider-Gold C
    Ann Neurol; 2003 Jul; 54(1):135-6; author reply 136-7. PubMed ID: 12838533
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrocephalus and myasthenia gravis: neurological manifestations in autoimmune polyendocrine syndrome type II.
    Morís G; Colunga D
    Acta Neurol Belg; 2023 Apr; 123(2):599-601. PubMed ID: 35020165
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case report of sister with Duane's syndrome and PGA, or myasthenia gravis].
    Noguchi M; Nonomura Y; Kanamori A; Yajima Y; Abe Y
    Nihon Naibunpi Gakkai Zasshi; 1994 May; 70(4):431-8. PubMed ID: 7958092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2.
    Lee SH; Kim MR; Kim JH; Kwon HS; Yoon KH; Son HY; Cha BY
    Gynecol Endocrinol; 2007 May; 23(5):252-6. PubMed ID: 17558682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglandular syndrome type II in association with Epstein-Barr virus: a case report.
    Roa A; Lew L; DiJohn D
    Clin Pediatr (Phila); 2008 Jul; 47(6):604-6. PubMed ID: 18566357
    [No Abstract]   [Full Text] [Related]  

  • 17. [Narcolepsy associated with autoimmune polyglandular syndrome].
    Castells I; Lucas A; Pizarro E; Escudero D
    Med Clin (Barc); 1999 May; 112(19):758-9. PubMed ID: 10394580
    [No Abstract]   [Full Text] [Related]  

  • 18. Polyglandular autoimmune endocrinopathy in type 2 diabetes.
    Kumar R; Reddy DV; Unnikrishnan AG; Bhadada SK; Agrawal NK; Singh SK
    J Assoc Physicians India; 2004 Dec; 52():999-1000. PubMed ID: 15884464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic consequences of autoimmune polyglandular syndrome type 1.
    Berger JR; Weaver A; Greenlee J
    Neurology; 2008 Jun; 70(23):2248-51. PubMed ID: 18519874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysphagia and dysarthria: unusual presentation of Myasthenia Gravis].
    Ferreira S; Lage P; Claro I; Alcântara J; Nunes J; Nobre Leitão C
    Acta Med Port; 2007; 20(5):463-6. PubMed ID: 18282445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.